# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
- SEC Filing In connection with the continued evaluation of strategic alternatives of Meta Materials Inc. (the "Company...
https://www.sec.gov/news/press-release/2024-77
Meta Materials shares are trading higher by 52.6% during Tuesday's session. The company late Monday announced an update on ...
BDRX: 110% | Biodexa Pharmaceuticals Presents Phase 2 Clinical Trial Results Of Its Newly-Licensed eRapa In Familial Adenomatou...